Wuhan Asia Heart Hospital

Wuhan Asia Heart Hospital

Private
Wuhan, HubeiHealthcare & Life Scienceshttps://www.wahh.com.cn

Last Round

Series D

2/9/2022

Total Funding Raised

$550M

Company Overview

Wuhan Asia Heart Hospital is a healthcare company that operates a network of heart hospitals specializing in heart surgery and cardiology examinations, supported by a skilled medical team to facilitate rapid recovery from heart-related conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cardiovascular hospitalheart surgerycardiac careinterventional cardiologyheart hospitalspecialized hospitalpediatric cardiologyheart transplantationprivate hospitalcongenital heart diseasechest pain centerhospital managementcorporate medical exams

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wuhan Asia Heart Hospital Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wuhan Asia Heart Hospital Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D2/9/2022
Series C9/18/2018
Series B1/13/2017

Wuhan Asia Heart Hospital Investors

Notable investors and investment history

InvestorRounds
Industrial and Commercial Bank of ChinaSeries D
Primavera Capital GroupSeries D
Legend CapitalSeries D
Hudson Bay Capital ManagementSeries D
BOCOM International Holdings Company LimitedSeries D
General AtlanticSeries D, Series C

Wuhan Asia Heart Hospital Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wuhan Asia Heart Hospital Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wuhan Asia Heart Hospital's valuation, stock price, and market status.

Firmographic Details

HeadquartersWuhan, Hubei
Employee Range105
Year Founded1999
Last Funding2/9/2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.